Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Summary

The purpose of the study is to evaluate the long-term safety and tolerability of Padsevonil administered at individualized doses as adjunctive treatment for subjects with drug-resistant epilepsy.

Timeline

Start

2018-08-27

Primary completion

2020-12-11

Completion

2020-12-11

Outcome

Outcome not reported

Stopped: “Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizure”

Drugs

Indications